Skip to main content
. Author manuscript; available in PMC: 2022 Jun 17.
Published in final edited form as: Pediatr Res. 2021 May 6;91(6):1391–1398. doi: 10.1038/s41390-021-01540-4

Figure 4:

Figure 4:

Effect of CaSR siRNA on CPAP-enhanced airway reactivity. In lung slices of wildtype mice, 48 hr exposure to CaSR siRNA resulted in reduced airway hyperreactivity compared to scrambled siRNA controls (A). Efficacy of CaSR siRNA was verified via αSM-actin and CaSR immunoreactivity in P21 day old mice (B), as summarized in (C). * indicates significant difference (p<0.05) between Ctrl and CPAP, # indicates significant CaSR siRNA effect (p<0.05). N=7–10 airways from 4–5 mice/group (three-way ANOVA with repeated measures).